Clinicopathological characteristics and rituximab addition to cytotoxic therapies in patients with rheumatoid arthritis and methotrexate‐associated large B lymphoproliferative disorders

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2559|67|1|70-80

ISSN： 0309-0167

Source： HISTOPATHOLOGY, Vol.67, Iss.1, 2015-07, pp. : 70-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Methotrexate‐related lymphoproliferative disorder arising in the gingiva of a patient with rheumatoid arthritis

By  

AUSTRALIAN DENTAL JOURNAL, Vol. 60, Iss. 3, 2015-09 ,pp. : 408-411

John Wiley & Sons Inc

Access to resources Recommend Favorite

Methotrexate‐associated lymphoproliferative disorder masquerading as multiple cerebral metastases

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 5, 2018-03 ,pp. : 628-628

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of Methotrexate, Anti–Tumor Necrosis Factor α, and Rituximab on the Immune Response to Influenza and Pneumococcal Vaccines in Patients With Rheumatoid Arthritis: A Systematic Review and Meta‐Analysis

By  

ARTHRITIS CARE AND RESEARCH, Vol. 66, Iss. 7, 2014-07 ,pp. : 1016-1026

John Wiley & Sons Inc

Access to resources Recommend Favorite

Response to Rituximab and Timeframe to Relapse in Rheumatoid Arthritis Patients: Association with B-Cell Markers

By Pyrpasopoulou Athina  

Molecular Diagnosis & Therapy, Vol. 14, Iss. 1, 2010-02 ,pp. : 43-48

Adis International

Access to resources Recommend Favorite

Serum rituximab levels and efficiency of B cell depletion: differences between patients with rheumatoid arthritis and systemic lupus erythematosus

By Reddy Venkat  

British Journal of Rheumatology , Vol. 52, Iss. 5, 2013-05 ,pp. : 951-952

Oxford University Press

Access to resources Recommend Favorite